Drug Trial Radar · NCT07428499
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Apr 2, 2026
Primary completion
Jun 30, 2030
Study completion Jun 30, 2030
Sponsor
- Lead sponsor
- ADARx Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study ADX-324-302 is an extension study for participants who complete the Phase 3 ADX-324-301 trial. The extension study will provide information about the safety and efficacy of additional dosing of ADX-324 in participants with Type I and Type II hereditary angioedema (HAE). The study will also include pharmacodynamic (PD), pharmacokinetic (PK), and health-related quality of life (HRQoL) measurements.
Conditions
- Hereditary Angioedema (HAE)
- Hereditary Angioedema - Type 1
- Hereditary Angioedema - Type 2
- HAE
Interventions
ADX-324 Dose Level 1Drug
siRNA duplex oligonucleotide
ADX-324 Dose Level 2Drug
siRNA duplex oligonucleotide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of ADX-324 in Participants with HAETime frame: Month 36
Locations
48 sites in 19 countries. Site status is shown where the registry gives one.
ADARx Clinical Site
Litchfield Park, Arizona · Not yet recruiting
ADARx Clinical Site
Little Rock, Arkansas · Not yet recruiting
ADARx Clinical Site
San Diego, California · Not yet recruiting
ADARx Clinical Site
Walnut Creek, California · Not yet recruiting
ADARx Clinical Site
Orlando, Florida · Not yet recruiting
ADARx Clinical Site
Chevy Chase, Maryland · Not yet recruiting
ADARx Clinical Site
Wheaton, Maryland · Not yet recruiting
ADARx Clinical Site
Detroit, Michigan · Not yet recruiting
ADARx Clinical Site
St Louis, Missouri · Not yet recruiting
ADARx Clinical Site
Las Vegas, Nevada · Recruiting
ADARx Clinical Site
New York, New York · Recruiting
ADARx Clinical Site
Cincinnati, Ohio · Not yet recruiting
ADARx Clinical Site
Columbus, Ohio · Not yet recruiting
ADARx Clinical Site
Toledo, Ohio · Not yet recruiting
ADARx Clinical Site
Hershey, Pennsylvania · Not yet recruiting
ADARx Clinical Site
Capital Federal, Buenos Aires, Argentina · Not yet recruiting
ADARx Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina · Not yet recruiting
ADARx Clinical Site
Adelaide, South Australia, Australia · Not yet recruiting
ADARx Clinical Site
Vienna, Austria · Not yet recruiting
ADARx Clinical Site
Edegem, Antwerpen, Belgium · Not yet recruiting
ADARx Clinical Site
Sofia, Bulgaria · Not yet recruiting
ADARx Clinical Site
Edmonton, Alberta, Canada · Not yet recruiting
ADARx Clinical Site
Ottawa, Ontario, Canada · Not yet recruiting
ADARx Clinical Site
Montreal, Quebec, Canada · Not yet recruiting
ADARx Clinical Site
Beijing, China · Not yet recruiting
ADARx Clinical Site
Harbin, China · Not yet recruiting
ADARx Clinical Site
Zhengzhou, China · Not yet recruiting
ADARx Clinical Site
Split, Croatia · Not yet recruiting
ADARx Clinical Site
Zagreb, Croatia · Not yet recruiting
ADARx Clinical Site
Hradec Králové, Czechia · Recruiting
ADARx Clinical Site
Prague, Czechia · Not yet recruiting
ADARx Clinical Site
Montpellier, France · Not yet recruiting
ADARx Clinical Site
Paris, France · Not yet recruiting
ADARx Clinical Site
Nice, Alpes-Maritimes, France · Not yet recruiting
ADARx Clinical Site
Tours, Indre-et-Loire, France · Not yet recruiting
ADARx Clinical Site
Tübingen, Baden-Wurttemberg, Germany · Not yet recruiting
ADARx Clinical Site
Hong Kong, Hong Kong · Not yet recruiting
ADARx Clinical Site
Budapest, Hungary · Not yet recruiting
ADARx Clinical Site
Ashkelon, Israel · Not yet recruiting
ADARx Clinical Site
Tel Aviv, Israel · Not yet recruiting
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.